Dr. Karis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
One Amgen Center Dr
Thousand Oaks, CA 91320
Education & Training
- NYU Grossman School of MedicineFellowship, Rheumatology, 2011 - 2013
- Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 2004 - 2007
- Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2004
Certifications & Licensure
- NY State Medical License 2005 - 2026
- CA State Medical License 2018 - 2022
- ME State Medical License Active through 2012
- CT State Medical License 2010 - 2010
- IL State Medical License 2007 - 2008
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Clinical Trials
- Study Evaluating Etanercept in the Treatment of Subjects With Ankylosing Spondylitis Start of enrollment: 2007 Feb 01
- Study of Etanercept Monotherapy vs Methotrexate Monotherapy for Maintenance of Rheumatoid Arthritis Remission Start of enrollment: 2015 Feb 20
- Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Efavaleukin Alfa in Participants With Systemic Lupus Erythematosus Start of enrollment: 2018 Apr 10
Publications & Presentations
PubMed
- 1 citationsImproving resource utilisation in SLE drug development through innovative trial design.Sandra Garces, Elaine Karis, Joan T Merrill, Anca D Askanase, Kenneth Kalunian
Lupus Science & Medicine. 2023-07-01 - 1 citationsExamining the potential direct cardiovascular benefit of tumor-necrosis factor inhibitor in rheumatoid arthritis: Natural and controlled direct effect analyses.Kazuki Yoshida, Leslie R Harrold, Nicole Middaugh, Hongshu Guan, Scott Stryker
Pharmacoepidemiology and Drug Safety. 2023-04-01 - Effects of Disease-Worsening Following Withdrawal of Etanercept or Methotrexate on Patient-Reported Outcomes in Patients With Rheumatoid Arthritis: Results From the SE...Jeffrey R Curtis, Bradley Stolshek, Paul Emery, Boulos Haraoui, Elaine Karis
Journal of Clinical Rheumatology. 2023-01-01
Professional Memberships
- Member
- Fellows-in-Training Post Fellowship
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: